Both in Biotechnology
Eloxx Pharmaceuticals vs Caribou Biosciences
Over the past year ELOX returned −17.5% and CRBU returned −65.1%; their daily moves had a correlation of 0.07.
ELOX −17.5% CRBU −65.1%Growth of $1, one year, split-adjusted
| Metric | ELOX | CRBU |
|---|---|---|
| Price | $13.00 | $0.4438 |
| Market cap | $52.5M | $47.6M |
| Today | +1.25% | +0.89% |
| 1 month | −15.6% | −62.7% |
| 6 months | — | −77.0% |
| Year to date | — | −72.1% |
| 1 year | — | −81.7% |
| Revenue growth (YoY) | — | −43.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −1619.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.7× |
| Net cash | $62.0M | $112.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 146.0% |
| Short % of float | 1.3% | 13.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).